Investor List:

Top Pharmaceuticals Series B Investors in Canada (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Hardware (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series A), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Hardware (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Hardware (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Digital Health (Series B), Investors in Hardware (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Hardware (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Robotics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in AI (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Series B), Investors in BioTech (Series A), Investors in Semiconductors (Series A), Investors in Semiconductors (Series B), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in AI (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Medical Devices (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AI (Series B), Investors in Material Science (Series A), Investors in BioTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in EnergyTech (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Canada (Other Lists), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Humayun H., Investor
Humayun H.
Investor
Sweet spot: $1M
Range: $100K - $10.0M
Investors in LatAm (Latin America), Investors in Mexico, Investors in Canada, Investors in United States, Investors in Asia, Investors in Europe
Investors in Wellness & Fitness (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series A), Investors in AI (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in AI (Series B), Investors in Diverse Investors (Other Lists), Investors in AI (Series A), Investors in BioTech (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Digital Health (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Wellness & Fitness (Series B), Investors in AI (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Therapeutics (Series B), Investors in Medical Devices (Series B), Investors in Therapeutics (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in Wellness & Fitness (Series A), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in AI (Series A), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in LatAm (Latin America) (Other Lists), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Wellness & Fitness (Seed), Investors in Robotics (Series B), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Robotics (Series A), Investors in Digital Health (Seed), Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in AI (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in Consumer Internet (Seed), Investors in Real Estate/PropTech (Seed), Investors in Real Estate/PropTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series A), Investors in Real Estate/PropTech (Series A), Investors in Consumer Internet (Series B), Investors in Real Estate/PropTech (Series B), Investors in Consumer Internet (Series B), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Real Estate/PropTech (Series B), Investors in Real Estate/PropTech (Series A), Investors in Real Estate/PropTech (Seed), Investors in Consumer Internet (Series B)
Photo of Thomas  (Tianyu) Piao, Angel
Thomas (Tianyu) Piao
Angel
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada
CL
Chandra Leo
Hbm Partners·Partner
Sweet spot: $15
Range: $10 - $25
Investors in Canada, Investors in United States, Investors in Europe
Photo of Wenwen He, Vice President at Cathay Health
Wenwen He
Cathay Health·Vice President
Sweet spot: $10.0M
Range: $5.0M - $15.0M
Investors in United Kingdom, Investors in France, Investors in United States, Investors in Canada, Investors in Europe
Investors in Health IT (Series A), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Series A), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in SaaS (Series B), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Diagnostics (Seed), Investors in New York City (Other Lists), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in SaaS (Seed), Investors in Diagnostics (Series B), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in SaaS (Seed), Investors in SaaS (Series A), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series B), Investors in Canada (Other Lists), Investors in Digital Health (Series B)
Photo of Eric Anschutz
Eric Anschutz
Sweet spot: $25K
Range: $10K - $250K
Investors in Boston (MA), Investors in San Francisco (CA), Investors in Shanghai, Investors in Los Angeles (CA), Investors in San Diego (CA), Investors in San Jose (CA), Investors in Oakland (CA), Investors in Emeryville (CA), Investors in Seattle (WA), Investors in British Columbia
Investors in Material Science (Seed), Investors in AI (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Seattle / Portland (Other Lists), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Seed), Investors in AI (Seed), Investors in Space (Series A), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Space (Seed), Investors in Space (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Space (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Space (Series A), Investors in AI (Series B), Investors in Space (Series A), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in BioTech (Series B), Investors in Material Science (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Space (Series B), Investors in Material Science (Series B), Investors in Space (Series B), Investors in British Columbia (Other Lists), Investors in Space (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Series B), Investors in DeepTech (Seed), Investors in DeepTech (Series B), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in DeepTech (Series B), Investors in Space (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Therapeutics (Series A), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series B), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Space (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Series B), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series B), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Seed), Investors in DeepTech (Pre-seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in AI (Seed)
Get new data & insights delivered to your inbox